Rankings
▼
Calendar
ALKS Q3 2020 Earnings — Alkermes plc Revenue & Financial Results | Market Cap Arena
ALKS
Alkermes plc
$5B
Q3 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$265M
+3.8% YoY
Gross Profit
$222M
83.7% margin
Operating Income
-$11M
-4.0% margin
Net Income
-$134,000
-0.1% margin
EPS (Diluted)
$-0.00
QoQ Revenue Growth
+7.1%
Cash Flow
Operating Cash Flow
$60M
Free Cash Flow
$54M
Stock-Based Comp.
$23M
Balance Sheet
Total Assets
$1.9B
Total Liabilities
$792M
Stockholders' Equity
$1.1B
Cash & Equivalents
$241M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$265M
$255M
+3.8%
Gross Profit
$222M
$213M
+4.2%
Operating Income
-$11M
-$54M
+80.1%
Net Income
-$134,000
-$53M
+99.7%
Revenue Segments
Product
$143M
99%
License
$1M
1%
Research And Development
$953,000
1%
← FY 2020
All Quarters
Q4 2020 →